Patents by Inventor Paul Warren Reddell

Paul Warren Reddell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TIGLIEN-3-ONE DERIVATIVES
    Publication number: 20230301960
    Abstract: The present invention relates to tiglien-3-one compounds and their use in methods of treating or preventing protozoal infections, bacterial infections, parasitic infections and cell proliferative disorders.
    Type: Application
    Filed: November 15, 2022
    Publication date: September 28, 2023
    Inventors: Paul Warren Reddell, Victoria Anne Gordon
  • BIOFILM DISRUPTION
    Publication number: 20220313648
    Abstract: The present invention relates to methods of dispersing biofilms comprising Gram-negative bacteria, the methods comprising exposing the biofilm to an epoxytiglienone compound or a salt thereof. Methods of treating infections comprising the localised administration, for example, topically or by injection, of an epoxytiglienone compound into or onto an established biofilm comprising Gram-negative bacteria to disrupt the structure of that biofilm and methods of preventing biofilms comprising Gram-negative bacteria forming or dispersing biofilms comprising Gram-negative biofilms that have formed on medical devices are also described.
    Type: Application
    Filed: June 19, 2020
    Publication date: October 6, 2022
    Applicant: QBIOTICS PTY LTD
    Inventors: David William THOMAS, Paul Warren REDDELL, Glen Mathew BOYLE, Jason Kingsley CULLEN, Victoria Anne GORDON, Katja Etel HILL, Lydia Charlotte POWELL, Manon F. PRITCHARD, Peter G. PARSONS
  • METHOD OF TREATING TUMOURS
    Publication number: 20220193023
    Abstract: The present invention relates to methods of treating tumours comprising the localised administration, for example, intratumourally or topically, of an epoxytiglienone compound (as a monotherapy) to cancerous tumours to generate a systemic anticancer C abscopal (anenestic) and/or bystander effect.
    Type: Application
    Filed: April 9, 2020
    Publication date: June 23, 2022
    Applicant: QBIOTICS PTY LTD
    Inventors: Victoria Anne GORDON, Paul Warren REDDELL, Glen Mathew BOYLE, Jason Kingsley CULLEN, Peter Gordon PARSONS
  • Combination therapy for the treatment or prevention of tumours
    Patent number: 11213506
    Abstract: The present invention relates to a combination therapy for tumours comprising the administration of an epoxytigliane compound and an immune checkpoint inhibitor. In particular embodiments, there is a method of treating a tumour and/or treating or preventing one or more bystander tumours with the therapy. Pharmaceutical compositions and kits containing epoxytigliane compounds and immune checkpoint inhibitors are also described.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: January 4, 2022
    Assignee: QBIOTICS PTY LTD
    Inventors: Paul Warren Reddell, Jason Kingsley Cullen, Glen Mathew Boyle, Peter Gordon Parsons, Victoria Anne Gordon
  • TIGLIEN-3-ONE DERIVATIVES
    Publication number: 20210196668
    Abstract: The present invention relates to tiglien-3-one compounds and their use in methods of treating or preventing protozoal infections, bacterial infections, parasitic infections and cell proliferative disorders.
    Type: Application
    Filed: March 17, 2021
    Publication date: July 1, 2021
    Inventors: Paul Warren Reddell, Victoria Anne Gordon
  • Tiglien-3-one derivatives
    Patent number: 10980769
    Abstract: The present invention relates to tiglien-3-one compounds and their use in methods of treating or preventing protozoal infections, bacterial infections, parasitic infections and cell proliferative disorders.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: April 20, 2021
    Assignee: QBIOTICS PTY LTD
    Inventors: Paul Warren Reddell, Victoria Anne Gordon
  • Methods and compositions for wound healing
    Patent number: 10822317
    Abstract: The present invention relates to epoxy-tigliane compounds and their use in promoting wound healing. In particular embodiments, the epoxy-tigliane compounds are epoxy-tigliaen-3-one compounds. Methods of inducing or promoting wound healing as well as methods of reducing scarring and improving cosmetic outcomes upon healing of a wound are described. Compounds and compositions for use in wound healing are also described.
    Type: Grant
    Filed: November 21, 2018
    Date of Patent: November 3, 2020
    Assignee: QBIOTICS PTY LTD
    Inventors: Paul Warren Reddell, Victoria Anne Gordon, Ryan Moseley, Robert Steadman, Rachael Louise Moses, Glen Mathew Boyle, Peter Gordon Parsons
  • TIGLIEN-3-ONE DERIVATIVES
    Publication number: 20200179325
    Abstract: The present invention relates to tiglien-3-one compounds and their use in methods of treating or preventing protozoal infections, bacterial infections, parasitic infections and cell proliferative disorders.
    Type: Application
    Filed: December 3, 2019
    Publication date: June 11, 2020
    Inventors: Paul Warren Reddell, Victoria Anne Gordon
  • COMBINATION THERAPY FOR THE TREATMENT OR PREVENTION OF TUMOURS
    Publication number: 20200030279
    Abstract: The present invention relates to a combination therapy for tumours comprising the administration of an epoxytigliane compound and an immune checkpoint inhibitor. In particular embodiments, there is a method of treating a tumour and/or treating or preventing one or more bystander tumours with the therapy. Pharmaceutical compositions and kits containing epoxytigliane compounds and immune checkpoint inhibitors are also described.
    Type: Application
    Filed: March 23, 2018
    Publication date: January 30, 2020
    Inventors: Paul Warren Reddell, Jason Kingsley Cullen, Glen Mathew Boyle, Peter Gordon Parsons, Victoria Anne Gordon
  • Tiglien-3-one derivatives
    Patent number: 10543188
    Abstract: The present invention relates to tiglien-3-one compounds and their use in methods of treating or preventing protozoal infections, bacterial infections, parasitic infections and cell proliferative disorders. The tiglien-3-one compounds are also used in methods of controlling pests in humans, animals, plants and the environment.
    Type: Grant
    Filed: October 2, 2018
    Date of Patent: January 28, 2020
    Assignee: QBIOTICS PTY LTD
    Inventors: Paul Warren Reddell, Victoria Anne Gordon
  • METHODS AND COMPOSITIONS FOR WOUND HEALING
    Publication number: 20190161462
    Abstract: The present invention relates to epoxy-tigliane compounds and their use in promoting wound healing. In particular embodiments, the epoxy-tigliane compounds are epoxy-tigliaen-3-one compounds. Methods of inducing or promoting wound healing as well as methods of reducing scarring and improving cosmetic outcomes upon healing of a wound are described. Compounds Sand compositions for use in wound healing are also described.
    Type: Application
    Filed: November 21, 2018
    Publication date: May 30, 2019
    Inventors: Paul Warren Reddell, Victoria Anne Gordon, Ryan Moseley, Robert Steadman, Rachael Louise Moses, Glen Mathew Boyle, Peter Gordon Parsons
  • TIGLIEN-3-ONE DERIVATIVES
    Publication number: 20190099397
    Abstract: The present invention relates to tiglien-3-one compounds and their use in methods of treating or preventing protozoal infections, bacterial infections, parasitic infections and cell proliferative disorders. The tiglien-3-one compounds are also used in methods of controlling pests in humans, animals, plants and the environment.
    Type: Application
    Filed: October 2, 2018
    Publication date: April 4, 2019
    Inventors: Paul Warren Reddell, Victoria Anne Gordon
  • Methods and compositions for wound healing
    Patent number: 10183921
    Abstract: The present invention relates to epoxy-tigliane compounds and their use in promoting wound healing. In particular embodiments, the epoxy-tigliane compounds are epoxy-tigliaen-3-one compounds. Methods of inducing or promoting wound healing as well as methods of reducing scarring and improving cosmetic outcomes upon healing of a wound are described. Compounds and compositions for use in wound healing are also described.
    Type: Grant
    Filed: April 17, 2014
    Date of Patent: January 22, 2019
    Assignee: QBiotics Limited
    Inventors: Paul Warren Reddell, Victoria Anne Gordon, Ryan Moseley, Robert Steadman, Rachael Louise Moses, Glen Mathew Boyle, Peter Gordon Parsons
  • Methods and compositions for wound healing
    Patent number: 10183922
    Abstract: The present invention relates to epoxy-tigliane compounds and their use in promoting wound healing. In particular embodiments, the epoxy-tigliane compounds are epoxy-tigliaen-3-one compounds. Methods of inducing or promoting wound healing as well as methods of reducing scarring and improving cosmetic outcomes upon healing of a wound are described. Compounds and compositions for use in wound healing are also described.
    Type: Grant
    Filed: February 6, 2017
    Date of Patent: January 22, 2019
    Assignee: QBiotics Limited
    Inventors: Paul Warren Reddell, Victoria Anne Gordon, Ryan Moseley, Robert Steadman, Rachael Louise Moses, Glen Mathew Boyle, Peter Gordon Parsons
  • Methods of lightening the skin
    Patent number: 9814659
    Abstract: Provided are methods of lightening skin by applying certain aromatic compounds or botanical extracts containing such compounds to the skin.
    Type: Grant
    Filed: April 2, 2012
    Date of Patent: November 14, 2017
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Chong Jin Loy, Khalid Mahmood, Claude Saliou, Paul Warren Reddell, Victoria Anne Gordon
  • Tiglien-3-one derivatives
    Patent number: 9770431
    Abstract: The present invention relates to tiglien-3-one compounds and their use in methods of treating or preventing protozoal infections, bacterial infections, parasitic infections and cell proliferative disorders. The tiglien-3-one compounds are also used in methods of controlling pests in humans, animals, plants and the environment.
    Type: Grant
    Filed: February 11, 2016
    Date of Patent: September 26, 2017
    Assignee: QBiotics Limited
    Inventors: Paul Warren Reddell, Victoria Anne Gordon
  • TIGLIEN-3-ONE DERIVATIVES
    Publication number: 20170143662
    Abstract: The present invention relates to tiglien-3-one compounds and their use in methods of treating or preventing protozoal infections, bacterial infections, parasitic infections and cell proliferative disorders. The tiglien-3-one compounds are also used in methods of controlling pests in humans, animals, plants and the environment.
    Type: Application
    Filed: February 7, 2017
    Publication date: May 25, 2017
    Inventors: Paul Warren Reddell, Victoria Anne Gordon
  • METHODS AND COMPOSITIONS FOR WOUND HEALING
    Publication number: 20170144981
    Abstract: The present invention relates to epoxy-tigliane compounds and their use in promoting wound healing. In particular embodiments, the epoxy-tigliane compounds are epoxy-tigliaen-3-one compounds. Methods of inducing or promoting wound healing as well as methods of reducing scarring and improving cosmetic outcomes upon healing of a wound are described. Compounds and compositions for use in wound healing are also described.
    Type: Application
    Filed: February 6, 2017
    Publication date: May 25, 2017
    Inventors: Paul Warren Reddell, Victoria Anne Gordon, Ryan Moseley, Robert Steadman, Rachael Louise Moses, Glen Mathew Boyle, Peter Gordon Parsons
  • TIGLIEN-3-ONE DERIVATIVES
    Publication number: 20160158187
    Abstract: The present invention relates to tiglien-3-one compounds and their use in methods of treating or preventing protozoal infections, bacterial infections, parasitic infections and cell proliferative disorders. The tiglien-3-one compounds are also used in methods of controlling pests in humans, animals, plants and the environment.
    Type: Application
    Filed: February 11, 2016
    Publication date: June 9, 2016
    Inventors: Paul Warren Reddell, Victoria Anne Gordon
  • Tiglien-3-one derivatives
    Patent number: 9289410
    Abstract: The present invention relates to tiglien-3-one compounds and their use in methods of treating or preventing protozoal infections, bacterial infections, parasitic infections and cell proliferative disorders. The tiglien-3-one compounds are also used in methods of controlling pests in humans, animals, plants and the environment.
    Type: Grant
    Filed: November 20, 2013
    Date of Patent: March 22, 2016
    Assignee: QBiotics Limited
    Inventors: Paul Warren Reddell, Victoria Anne Gordon